Uric Acid

If you have had a kidney stone, a gout flare, or a stubbornly high uric acid blood test, this collection answers a question your routine labs cannot: is the problem too much uric acid being made, or kidneys not getting rid of enough? That distinction changes which medication actually works for you and how aggressively to adjust your diet.

Uric acid is the end product when your body breaks down purines, which come from your own cell turnover, dietary protein, and fructose. Roughly two-thirds of it leaves through your kidneys, and how much shows up in 24 hours is one of the cleanest windows into how your body handles this waste product.

What This Test Actually Captures

Uric acid is a small molecule, not a hormone or enzyme. It is generated mainly in your liver and small intestine, and your kidneys filter, reabsorb, and secrete it through specialized transporters in the proximal tubule (the part of the kidney that fine-tunes which substances are kept and which are sent out in urine). A 24-hour urine collection captures the net output of that whole system over a full day, which is why it tracks both production and kidney handling at once.

High output (sometimes called hyperuricosuria) usually means your body is overproducing uric acid, often from high purine or fructose intake, or from increased cell turnover. Low output, especially when paired with a high blood uric acid level, points to your kidneys reabsorbing too much and not letting enough out. Each pattern points to different causes and different treatments.

Gout: Splitting Overproducers from Underexcretors

Gout is the disease most closely tied to this test. Knowing whether you are an overproducer or an underexcretor matters because it informs which class of medication makes biological sense for you: drugs that block production versus drugs that push the kidney to release more uric acid.

Standard gout cutoffs label excretion above 600 to 800 mg per day as overproduction, but healthy men can intermittently exceed 800 mg without having gout, so a stricter threshold of 1000 mg per day better identifies true overproduction. In gout cohorts, average 24-hour excretion runs around 640 to 670 mg per day, with wide individual scatter.

During an acute gout flare, the picture flips temporarily: blood uric acid drops while urine excretion rises, driven by inflammatory signaling and cortisol. That means a single test taken in the middle of a flare can mislead you about your usual pattern.

Kidney Stones

Pure uric acid stones form when the urine is acidic enough to push uric acid out of solution, and 24-hour testing helps map this risk. People with metabolic syndrome features tend to show higher uric acid output, lower urine pH, and more uric acid stones. Obese and underweight stone formers also more often show abnormalities like hyperuricosuria, supporting targeted medical therapy in these groups.

One important nuance: for calcium oxalate stones, higher urinary uric acid does not necessarily mean higher stone risk. In a large cohort of 6,217 people, higher urinary uric acid was actually associated with lower stone risk, while higher calcium, oxalate, phosphorus, and sodium drove most of the danger. This is why uric acid is best read alongside the rest of the stone panel rather than in isolation.

Reconciling the Counterintuitive Stone Finding

If higher urinary uric acid raises risk for one type of stone (pure uric acid stones, driven by acidic urine and overproduction) but appears protective in calcium oxalate disease, the apparent contradiction resolves once you recognize this is a phenotype indicator, not a simple high-bad, low-good marker. The same number means different things depending on your stone chemistry, urine pH, and metabolic context. Read 24-hour uric acid alongside urine pH, citrate, calcium, and oxalate to interpret it correctly for your situation.

Chronic Kidney Disease and Cardiometabolic Risk

In chronic kidney disease (CKD), urinary uric acid handling may track kidney damage better than blood levels alone. In a study of 1,042 people with CKD, those with lower urinary uric acid excretion and a lower urinary uric acid to creatinine ratio had a higher risk of progressing to kidney failure, suggesting that excessive tubular reabsorption of urate is harmful to the kidney.

In type 2 diabetes, the combination of high blood uric acid plus low urinary excretion (the underexcretor pattern) was tied to the highest prevalence of CKD and protein in the urine across 2,846 patients. Low excretion in advanced CKD also tracks with biomarkers of tubular injury.

Reference Ranges

There is no single universally agreed-upon 24-hour urinary uric acid cutoff. Lab assays differ, hydration shifts the result, and even the same person can vary substantially month to month. The numbers below come from research in adult populations and are best used as orientation, not absolute targets. Compare your own results within the same lab over time.

Source: Yu et al., Rheumatology, 2004 (n=12 healthy men); Choi et al., 2018 (gout cohort, n=90); Song et al., 2015 (gout cohort, n=51); Lopez Iglesias et al., PLOS ONE, 2024 (advanced CKD, n=120). Interpret your number alongside your blood uric acid, urine pH, and kidney function for the most useful read.

When Results Can Be Misleading

A single 24-hour collection is informative but imperfect. Several real-world factors can distort the number without telling you anything meaningful about your underlying biology.

• Collection errors: missed voids, over-collection, or extreme volumes (under 700 or over 4000 mL) frequently invalidate samples. Long-term programs have had to exclude up to 3% of collections for these reasons.
• Recent diet and alcohol: a high-purine meal (organ meats, seafood) or alcohol in the day before collection can transiently push excretion up.
• Acute gout flare: during a flare, blood uric acid temporarily falls and urinary excretion rises. Testing during a flare misclassifies your usual pattern.
• Drug confounders: dapagliflozin, empagliflozin, and other SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors used for diabetes and heart failure) raise urinary uric acid by linking it to glucose excretion. Losartan also increases urinary excretion. These shift the number through medication effects, not because of disease.

Why One Reading Is Not Enough

Even healthy people fluctuate substantially across days and months. In a study of 12 healthy men tracked repeatedly, mean excretion was around 651 mg per day, and many had transient overexcretion above the standard 800 mg cutoff. That kind of scatter means a single "high" or "normal" result can mislead you in either direction.

Get a baseline collection. If you are starting a new diet, urate-lowering medication, or weight loss program, retest in 3 to 6 months to confirm the change is real. If you are an active stone former or managing gout, retest at least annually. Serial collections done at 6-month intervals or longer have been shown to meaningfully improve stone-risk parameters in active stone disease.

What to Do If Your Result Is Abnormal

An abnormal 24-hour uric acid is a starting point, not a diagnosis. Pair it with other tests to make decisions:

• With your serum uric acid: if blood uric acid is high but urine is low, you are likely an underexcretor. If both are high, you are likely an overproducer. This shapes whether xanthine oxidase inhibitors (production blockers) or uricosurics (excretion enhancers) make more sense.
• With a full stone risk panel: order alongside urine pH, calcium, oxalate, citrate, sodium, and supersaturation if you have had a stone. The pattern, not the uric acid number alone, drives treatment.
• With kidney function: check eGFR, cystatin C, and urine albumin. In CKD, low urinary uric acid excretion is associated with worse kidney trajectory, so the pattern matters even more.
• Specialist involvement: a rheumatologist can help calibrate gout therapy, and a nephrologist or urologist can guide stone prevention. If you are on an SGLT2 inhibitor, losartan, or vitamin C, share that with whoever is interpreting the result.

If your result is borderline, retest before starting medication. If it is clearly abnormal and matches your symptoms or stone history, the test has done its job: it points the next decision in the right direction.